Neumora Therapeutics (NMRA) Institutional Ownership → 3 Dirt-Cheap Stocks You Can’t Afford to Ignore (From TradingTips) (Ad) Free NMRA Stock Alerts $9.95 +0.02 (+0.20%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Neumora Therapeutics (NASDAQ:NMRA)CurrentInstitutional OwnershipPercentage47.65%Number ofInstitutional Buyers(last 12 months)21TotalInstitutional Inflows(last 12 months)$204.45MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$641.08K Get NMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NMRA Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Neumora Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Artal Group S.A.2,924,052$40.21M1.0%+14.5%1.833% 5/16/2024 Kennedy Capital Management LLC136,828$1.88M0.0%N/A0.086% 5/15/2024 Baker BROS. Advisors LP633,851$8.72M0.1%N/A0.397% 5/15/2024 Price T Rowe Associates Inc. MD752,924$10.35M0.0%N/A0.472% 5/14/2024 Nan Fung Group Holdings Ltd63,315$871K0.8%N/A0.040% 5/10/2024 Vanguard Group Inc.334,330$4.60M0.0%-12.2%0.210% 5/3/2024 Callan Capital LLC204,987$2.82M0.2%N/A0.129% 5/1/2024 Auour Investments LLC105,087$1.45M0.5%N/A0.066% 4/23/2024 Addis & Hill Inc314,821$4.19M3.6%N/A0.198% 4/22/2024 Windmill Hill Asset Management Ltd26,121$359K0.1%N/A0.016% 2/14/2024 Avidity Partners Management LP1,990,632$33.94M1.2%+10.6%1.304% 2/13/2024 Tower Research Capital LLC TRC2,558$44K0.0%N/A0.002% 2/6/2024 Amalgamated Bank1,709$29K0.0%N/A0.001% 2/1/2024 New York State Common Retirement Fund6,900$118K0.0%N/A0.005% 1/30/2024 Strs Ohio3,200$54K0.0%N/A0.002% 1/12/2024 SG Americas Securities LLC6,308$108K0.0%N/A0.004% 12/6/2023 Citigroup Inc.14,416$203K0.0%N/A0.009% 11/15/2023 Laurion Capital Management LP21,557$304K0.0%N/A0.014% 11/14/2023 Soros Fund Management LLC10,000$141K0.0%N/A0.007% 11/14/2023 Avidity Partners Management LP1,800,000$25.40M1.0%N/A1.179% 11/13/2023 FMR LLC5,624,353$79.36M0.0%N/A3.683% 11/9/2023 Johnson & Johnson912,128$12.87M4.7%N/A0.597% 10/23/2023 WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST3,309,124$46.69M0.6%N/A2.178% (Data available from 1/1/2016 forward) NMRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NMRA shares? During the previous two years, 22 institutional investors and hedge funds held shares of Neumora Therapeutics. The most heavily invested institutionals were FMR LLC ($79.36M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($46.69M), Artal Group S.A. ($40.21M), Avidity Partners Management LP ($33.94M), Johnson & Johnson ($12.87M), Price T Rowe Associates Inc. MD ($10.35M), and Baker BROS. Advisors LP ($8.72M).Learn more on NMRA's institutional investors. What percentage of Neumora Therapeutics stock is owned by institutional investors? 47.65% of Neumora Therapeutics stock is owned by institutional investors. Learn more on NMRA's institutional investor holdings. Which institutional investors have been buying Neumora Therapeutics stock? Of the 21 institutional investors that purchased Neumora Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.62M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($3.31M), Avidity Partners Management LP ($1.99M), Johnson & Johnson ($912.13K), Price T Rowe Associates Inc. MD ($752.92K), Baker BROS. Advisors LP ($633.85K), and Artal Group S.A. ($371.35K). How much institutional buying is happening at Neumora Therapeutics? Institutional investors have bought a total of 14,512,169 shares in the last 24 months. This purchase volume represents approximately $204.45M in transactions. Which Neumora Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Neumora Therapeutics stock in the last 24 months: Vanguard Group Inc. ($46.62K). How much institutional selling is happening at Neumora Therapeutics? Institutional investors have sold a total of 46,624 shares in the last 24 months. This volume of shares sold represents approximately $641.08K in transactions. Related Companies: CRISPR Therapeutics Institutional Ownership Krystal Biotech Institutional Ownership ImmunityBio Institutional Ownership Immunovant Institutional Ownership Twist Bioscience Institutional Ownership Denali Therapeutics Institutional Ownership SpringWorks Therapeutics Institutional Ownership Arcellx Institutional Ownership Novavax Institutional Ownership Apogee Therapeutics Institutional Ownership This page (NASDAQ:NMRA) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.